Two Sigma Investments’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.63M | Buy |
3,509,613
+632,429
| +22% | +$1.13M | ﹤0.01% | 2046 |
|
|
2025
Q4 | $5.38M | Buy |
2,877,184
+2,475,418
| +616% | +$4.76M | 0.01% | 1660 |
|
|
2025
Q3 | $514K | Buy |
+401,766
| New | +$544K | ﹤0.01% | 2967 |
|
|
2025
Q2 | – | Sell |
-542,200
| Closed | -$640K | – | 3442 |
|
|
2025
Q1 | $640K | Sell |
542,200
-571,377
| -51% | -$876K | ﹤0.01% | 2411 |
|
|
2024
Q4 | $2.04M | Buy |
1,113,577
+648,407
| +139% | +$1.27M | ﹤0.01% | 1697 |
|
|
2024
Q3 | $791K | Sell |
465,170
-370,250
| -44% | -$608K | ﹤0.01% | 2250 |
|
|
2024
Q2 | $1.14M | Buy |
835,420
+646,728
| +343% | +$1.31M | ﹤0.01% | 1911 |
|
|
2024
Q1 | $708K | Buy |
188,692
+115,119
| +156% | +$674K | ﹤0.01% | 2164 |
|
|
2023
Q4 | $722K | Sell |
73,573
-289,084
| -80% | -$2.36M | ﹤0.01% | 2263 |
|
|
2023
Q3 | $3.03M | Sell |
362,657
-402,115
| -53% | -$4.6M | 0.01% | 1143 |
|
|
2023
Q2 | $10.2M | Buy |
764,772
+704,972
| +1,179% | +$8.57M | 0.03% | 641 |
|
|
2023
Q1 | $692K | Hold |
59,800
| – | – | ﹤0.01% | 2057 |
|
|
2022
Q4 | $489K | Buy |
+59,800
| New | +$515K | ﹤0.01% | 2034 |
|
|
2022
Q3 | – | Sell |
-4,487,462
| Closed | -$19.8M | – | 2724 |
|
|
2022
Q2 | $19.8M | Buy |
4,487,462
+1,399,307
| +45% | +$8.5M | 0.07% | 327 |
|
|
2022
Q1 | $28.1M | Buy |
3,088,155
+2,699,194
| +694% | +$31.1M | 0.08% | 304 |
|
|
2021
Q4 | $7.96M | Sell |
388,961
-532,651
| -58% | -$12.9M | 0.02% | 916 |
|
|
2021
Q3 | $23.5M | Sell |
921,612
-591,117
| -39% | -$17.5M | 0.06% | 408 |
|
|
2021
Q2 | $52.9M | Buy |
1,512,729
+97,846
| +7% | +$2.85M | 0.14% | 193 |
|
|
2021
Q1 | $47.1M | Buy |
+1,414,883
| New | +$49.5M | 0.14% | 187 |
|
|
2020
Q3 | – | Sell |
-28,694
| Closed | -$99K | – | 3542 |
|
|
2020
Q2 | $99K | Buy |
+28,694
| New | +$97.7K | ﹤0.01% | 2788 |
|
|
2018
Q1 | – | Sell |
-140,298
| Closed | -$370K | – | 3488 |
|
|
2017
Q4 | $370K | Buy |
+140,298
| New | +$491K | ﹤0.01% | 2627 |
|
|
2016
Q2 | – | Sell |
-111,292
| Closed | -$946K | – | 3199 |
|
|
2016
Q1 | $946K | Buy |
+111,292
| New | +$1.09M | ﹤0.01% | 1628 |
|
|
2015
Q1 | – | Sell |
-63,466
| Closed | -$498K | – | 2817 |
|
|
2014
Q4 | $498K | Buy |
+63,466
| New | +$406K | ﹤0.01% | 1723 |
|
|
2013
Q4 | – | Sell |
-29,854
| Closed | -$165K | – | 2323 |
|
|
2013
Q3 | $165K | Buy |
29,854
+2,954
| +11% | +$10.3K | ﹤0.01% | 1682 |
|
|
2013
Q2 | $68K | Buy |
+26,900
| New | +$67K | ﹤0.01% | 1911 |
|
Other funds holding PACB
AIM
VCM
NAMA
